- Home
- FN vs RVMD Comparison
FN vs RVMD Comparison
Compare FN & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FN
- RVMD
- Stock Information
- Founded
- FN 1999
- RVMD 2014
- Country
- FN Cayman Islands
- RVMD United States
- Employees
- FN N/A
- RVMD N/A
- Industry
- FN Telecommunications Equipment
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FN Utilities
- RVMD Health Care
- Exchange
- FN Nasdaq
- RVMD Nasdaq
- Market Cap
- FN 8.3B
- RVMD 8.7B
- IPO Year
- FN 2010
- RVMD 2020
- Fundamental
- Price
- FN $222.04
- RVMD $41.33
- Analyst Decision
- FN Buy
- RVMD Strong Buy
- Analyst Count
- FN 8
- RVMD 13
- Target Price
- FN $247.88
- RVMD $65.15
- AVG Volume (30 Days)
- FN 925.0K
- RVMD 1.2M
- Earning Date
- FN 02-03-2025
- RVMD 02-26-2025
- Dividend Yield
- FN N/A
- RVMD N/A
- EPS Growth
- FN 29.03
- RVMD N/A
- EPS
- FN 8.94
- RVMD N/A
- Revenue
- FN $3,122,632,000.00
- RVMD $742,000.00
- Revenue This Year
- FN $20.54
- RVMD N/A
- Revenue Next Year
- FN $12.86
- RVMD $1,855.56
- P/E Ratio
- FN $24.93
- RVMD N/A
- Revenue Growth
- FN 14.83
- RVMD N/A
- 52 Week Low
- FN $159.69
- RVMD $28.95
- 52 Week High
- FN $281.79
- RVMD $62.40
- Technical
- Relative Strength Index (RSI)
- FN 48.75
- RVMD 44.66
- Support Level
- FN $201.96
- RVMD $40.13
- Resistance Level
- FN $254.61
- RVMD $42.68
- Average True Range (ATR)
- FN 13.33
- RVMD 1.41
- MACD
- FN 2.10
- RVMD 0.10
- Stochastic Oscillator
- FN 42.71
- RVMD 26.42
About FN Fabrinet
Fabrinet provides advanced optical packaging and precision optical, electro-mechanical, and electronic manufacturing services to original equipment manufacturers of complex products, such as optical communication components, modules and sub-systems, industrial lasers, automotive components, medical devices, and sensors. The company offers a broad range of advanced optical and electro-mechanical capabilities across the entire manufacturing process, including process design and engineering, supply chain management, manufacturing, complex printed circuit board assembly, advanced packaging, integration, final assembly, and testing. The company generates the majority of its revenue from North America and Asia-Pacific, with the rest from Europe.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.